CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Cro
  • Top CROs

Cro 2021

Top 10 CROs - 2021

Top 10 CROs - 2021

New categories of emerging biologics and advances in cell and gene therapies are driving an evolutionary change in the contract research organization industry as these companies adapt their organizations to supply the services needed today. The rapid growth and uptake of technologies, such as CRISPR, CAR T cells, bispecifics and more, are significantly influencing the landscape of biotech and pharma drug development. To keep pace and provide the required support, CROs are investing in cutting-edge science and growing their service offerings to facilitate the field.

The last few years have seen tremendous consolidation in both the pharmaceutical and contract research industries. The impact among pharma companies has created a heightened demand for productivity. Consequently, CROs have struggled to find their footing in a business where the number of customers has shrunk and the demand for speed and cost-effectiveness has risen. Delivering service excellence when customers' names and addresses are changing regularly is a challenge, resulting in disrupted continuity, broken lines of communication, and policies and relationships thrown into disarray.

Among the many ways CROs can help increase productivity, the greatest potential lies in the application of their scientific expertise. Pharma companies possess indisputable expertise in a variety of areas, but they cannot span the entire spectrum of drug discovery and development. A CRO's scientific acumen can offer a unique perspective as a consultant focused on providing specific solutions. This is most important at the earliest levels of research.

CROs are unique in that they have seen and solved an enormous variety of challenges. What distinguishes a preferred partner from an average CRO is how well they've learned from their experience. A knowledge-based CRO can apply valuable intellectual resources to a wide scope of issues, making it a powerful ally.

The drug discovery and development industry faces formidable challenges, but the opportunities are there for those with the tools to exploit them. How significant a role CROs will play depends on their ability to prove their long-term worth by providing not just services but solutions.

We present to you, “Top 10 CROs 2021.”

Top 10 CROs - 2021

Nominate a Company

Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.

* 

captcha
Can't read the image? click here to refresh

Thank You!

checkmark

We are glad to receive your nomination. Our editorial team and evaluation panel will review your submission. Thank you for taking the time to highlight an organization driving impactful change in Lifescience Review.

Data not inserted

    Top CROs

    ★Featured Companies
    Frontage
    Frontage
    Read full profile →
    Frontage provides integrated, science-driven product development services, ranging all the way from drug candidate evaluation to drug development. Today, the company is enabling many innovator, generic, and consumer health companies of all sizes to file IND, NDA, ANDA, BLA and 505(b)(2) submissions in global markets allowing for successful development of important therapies and products for patients. Frontage is committed to providing rigorous scientific expertise to ensure the highest quality and compliance. With the company’s assistance, the clients are able to advance hundreds of molecules through development to commercial launch in global markets ... read full profile
    Icon Plc
    Icon Plc
    Read full profile →
    ICON plc offers a full range of consulting, development and commercialisation services that enable pharmaceutical, biotechnology, medical device, and government and public health organisations to accelerate the development of drugs and devices. The company develops integrated technologies to significantly enhance the efficiency and productivity of its clients’ drug and device development programs, providing true transparency across all areas of a stud ... read full profile
    MabPlex International
    MabPlex International
    Read full profile →
    MabPlex provides global CRO/CMO services in the development and manufacturing of biopharmaceuticals. The company offers contract services from DNA to finished biopharmaceutical goods. As a one-stop-shop for its partners, MabPlex provides services, all the way from early-stage development to commercialization, covering the entire spectrum—from gene sequencing, cell line development, process characterization, conjugation optimization to Current Good Manufacturing Practice (cGMP) for clinical and commercial manufacturing of final drug product ... read full profile
    Machaon Diagnostics
    Machaon Diagnostics
    Read full profile →
    Founded in 2003, Machaon Diagnostics specializes in the diagnosis and monitoring of coagulation, platelet, rare disease, and genetics. Operating as a clinical reference laboratory, the company has grown into a team of clinicians, scientists, consultants, and technologists that bring more than 400 years of combined expertise to the field of laboratory medicine. Machaon Diagnostics employs a NexGen sequencing technique allowing for the rapid detection (<48 hours) of over 150 known or suspected mutations, deletions, and polymorphisms previously reported as associated with aHUS, which is a life-threatening, progressive, and genetic disease ... read full profile
    Tergus Pharma
    Tergus Pharma
    Read full profile →
    Tergus Pharma is an end-to-end service provider for topical pharmaceuticals development. The company acts as an extension of their client’s team and provides support through the entire drug development lifecycle. With their services, pharma companies do not need to worry about the nuances of commercial drug development and manufacturing processes. Starting with high-quality R&D services at the pre-clinical stage, Tergus extends its capabilities to early skin biology services and clinical supplies manufacturing to deliver end-to-end development continuity ... read full profile
    Crown Bioscience
    Crown Bioscience
    Crown Bioscience, Inc. is a platform technology company providing drug discovery and development services in the areas of Oncology and Inflammation. CrownBio helps biopharmaceutical companies solve some of today's most pressing challenges in oncology with an offering of end-to-end preclinical solutions, a unique collection of ready-to-run, well-validated in vitro, in vivo, and ex vivo models, and cutting-edge technologies
    Medpace
    Medpace
    Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective
    NAMSA
    NAMSA
    Helping medical device Sponsors improve healthcare since 1967, NAMSA is the only 100% medical device-focused, full continuum Contract Research Organization (CRO). Driven by our global regulatory expertise and in-depth therapeutic knowledge, NAMSA is dedicated to accelerating medical device product development, offering only the most proven solutions to move clients’ products through the development lifecycle efficiently and cost-effectively. From medical device testing; regulatory, reimbursement and quality consulting; and clinical research services, we are the industry’s premier, trusted partner for successful development and commercialization outcomes
    Parexel
    Parexel
    Parexel is focused on the development of innovative new therapies to improve the world’s health. They do this by providing a suite of groundbreaking biopharmaceutical development services that help customers across the globe transform scientific discoveries into new treatments for patients. From clinical trial design to regulatory and consulting services to commercial and market access, their therapeutic, technical, and functional ability is underpinned by a deep conviction in what they do
    QPS Holdings
    QPS Holdings
    QPS is a GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, preclinical, and clinical drug development services. An award-winning leader focused on bioanalytics and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction and turnkey laboratories and facilities. They are passionate about their work, creating value for patients and customers while generating opportunities for employees to thrive

CRO Info

Q1
What Do Contract Research Organizations Do for Life Sciences Companies?
Contract Research Organizations, or CROs, help pharmaceutical, biotechnology and medical device companies manage clinical research that may be difficult to handle fully in-house. Their work can include study design, site coordination, patient recruitment, data management, safety monitoring and regulatory documentation. Top Contract Research Organizations often act as operational partners, helping sponsors move studies forward while maintaining quality, timelines and compliance standards. The strongest CROs combine scientific understanding with organized trial execution, especially in complex or fast-moving studies.
Q2
Why Do Top Contract Research Organizations Matter Now?
Top Contract Research Organizations matter because clinical development has become more demanding and resource-intensive. Sponsors face tighter budgets, more complex protocols, greater recruitment challenges and growing pressure to generate reliable data faster. Many studies now involve decentralized trial models, multiple sites and stricter reporting expectations. CROs help reduce that operational burden by providing experienced teams, established site networks and systems already designed for regulated research environments.
Q3
How Should Sponsors Evaluate Top Contract Research Organizations?
Sponsors should look beyond company size and focus on how a CRO performs during real trial pressure. Important areas include therapeutic expertise, site activation speed, monitoring quality, communication practices, data management and handling of protocol changes or enrollment delays. Strong CROs should also show clear study governance, staff continuity and structured escalation processes. A polished proposal matters less than consistent execution during active studies.
Q4
What Value Do CRO Services Create for Sponsors?
Good CRO support helps reduce delays and operational friction across clinical development. Top Contract Research Organizations can improve study coordination, strengthen documentation quality and help sponsors avoid issues involving weak recruitment, inconsistent reporting or delayed site activity. They also give organizations access to experienced research teams without building every capability internally. For many sponsors, especially smaller biotech companies, that support can make the difference between a study that progresses steadily and one that struggles to stay on track.
Q5
How Are Technology and Expertise Changing CRO Services?
Technology is changing how CROs manage studies, monitor patients and review data. Electronic data capture, remote monitoring, eConsent systems and analytics dashboards can improve visibility and reduce manual gaps. Still, technology alone does not guarantee a successful study. Experienced clinical teams are still needed to manage site relationships, resolve queries, monitor enrollment risks and maintain trial quality under real-world conditions.
Q6
What Should Sponsors Prioritize When Comparing CRO Providers?
Sponsors should prioritize operational fit, communication quality and study experience over scale alone. A large CRO may work well for global trials, while a smaller specialized organization may be stronger in a specific therapeutic area or patient population. Buyers should review team experience, quality systems, recruitment assumptions, reporting practices and transparency around timelines. The best CROs are usually the ones that communicate risks early, manage problems directly and keep studies organized as conditions change.
Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://cro.lifesciencesreviewapac.com/vendors/top-cros-2021.html